Assertio Holdings, Inc. (ASRT) intrinsic value & 10-year financials

Assertio Holdings, Inc. (ASRT) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue shrank 10.4% a year to $118.7M, with an average return on invested capital of -33.0%.

Graham intrinsic value
—
Revenue (FY2025)
$118.7M
Revenue growth (8-yr CAGR)
-10.4%
ROIC (10-yr avg)
-33.0%
Free cash flow (FY2025)
—

ASRT 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $118.7M -$30.4M -$4.74 — -18.1% -18.4%
FY2024 $125.0M -$21.6M -$0.23 $26.4M -19.6% -22.8%
FY2023 $152.1M -$331.9M -$4.67 $49.0M -160.1% -146.6%
FY2022 $156.2M $109.6M $2.03 $78.3M 25.2% 21.5%
FY2021 $111.0M -$1.3M -$0.03 $5.5M 8.5% 7.2%
FY2020 $106.3M -$28.1M -$0.27 -$65.6M -77.3% -20.6%
FY2019 $229.5M -$217.2M -$3.07 $89.0M -84.7% -51.0%
FY2018 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Assertio Holdings, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Assertio Holdings, Inc. has historically struggled to out-earn its cost of capital, averaging just -33.0% ROIC.

Assertio Holdings, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Assertio Holdings, Inc. is modeled at -10.4% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-21.54 per share.

ASRT stock: frequently asked questions

What is the intrinsic value of Assertio Holdings, Inc. (ASRT) stock?

Graham's formula only works with positive earnings. Assertio Holdings, Inc. reported diluted EPS of -$4.74 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

What is ASRT's return on invested capital?

Average ROIC over the last 8 fiscal years was -33.0%, and average return on equity was -52.6%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ASRT data come from?

From Assertio Holdings, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 8, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks